APONTIS PHARMA Deutschland GmbH & Co. KG

APONTIS PHARMA is a pharmaceutical company focused on the commercialization of innovative pharmaceutical products to General Practitioners (GPs) and Internal Medicine Specialists in Germany.


APONTIS PHARMA emerged in 2018 as a spin-off from a global pharmaceutical company UCB. APONTIS PHARMA builds on its long-standing UCB's and Schwarz Pharma's heritage.